Lateral Flow Immunoassay Reader Technologies for Quantitative Point-of-Care Testing

Jongwon Park1

  • 1Department of Biomedical Engineering, Kyungil University, Gyeongsan 38428, Korea.

Insights

Lateral flow immunoassays, initially for qualitative tests like COVID-19 antigen tests, are evolving for quantitative analysis. New sensor technologies and smartphone integration promise improved point-of-care diagnostics.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Point-of-Care Diagnostics

Background:

  • Lateral flow immunoassays (LFAs) have a 60-year history, primarily used for qualitative detection (e.g., pregnancy tests, COVID-19 antigen tests).
  • The demand for quantitative LFAs is rapidly increasing across diverse scientific and medical fields.
  • Technological advancements are driving the evolution of LFAs beyond simple qualitative results.

Purpose of the Study:

  • To review research trends in quantitative lateral flow immunoassay readers.
  • To classify readers based on sensor technologies employed for quantitative analysis.
  • To explore the integration of new technologies and systems for enhanced LFA quantification.

Main Methods:

  • Classification of quantitative LFA readers by sensor technology (optical, magnetic, photothermal, electrochemical).
  • Review of research trends in reader development and associated assay designs.
  • Examination of emerging technologies like smartphone integration for LFA analysis.

Main Results:

  • Various sensor technologies are being developed for quantitative LFAs, focusing on miniaturization, cost reduction, and improved performance.
  • Integration with smartphones offers a pathway for accessible, portable quantitative LFA analysis.
  • Specific systems for quantitative COVID-19 testing are highlighted.

Conclusions:

  • Quantitative LFAs are becoming increasingly important, moving beyond traditional qualitative applications.
  • Advancements in sensor technology and system integration are crucial for the future of rapid, quantitative point-of-care diagnostics.
  • LFAs with quantitative capabilities, enhanced by new technologies, will significantly impact disease diagnosis and monitoring.

Related Concept Videos